Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 5,500 shares at $64.88 ($362K) on 2026-02-04, disclosed to the SEC on 2026-02-04.
Open-market sale of $362k APGE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.88 | 2,481 | $161K | 44.5% |
| 2 | $65.83 | 1,420 | $93K | 25.8% |
| 3 | $66.85 | 1,299 | $87K | 24.0% |
| 4 | $67.88 | 100 | $7K | 1.9% |
| 5 | $68.94 | 200 | $14K | 3.8% |
| Total | $65.79 avg | 5,500 |
| $362K |
| 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |